Maggie®

Maggie® is a cartridge-based autoinjector technology built with our market-proven Needle Isolation Technology (NIT®).

<p>Maggie 3.0 ml autoinjector wit the cap off for SHL Medical</p>

Meet Maggie® 3.0 mL

Maggie_horizontal

For specific and large-volume formulation

Maggie® accommodates a wider variety of formulation characteristics and volumes that are not possible with pre-filled syringe-based autoinjectors

Specification

Viscosity
high
Volume
3.0 ml
Device type
Disposable autoinjector
Primary container
Cartridge with pre-installed needle (NIT®)
Route of administration
Subcutaneous
Connectivity
No
Dosage type
Fixed dose | Optional automated priming and titration
Activation method
Needle cover
Injection feedback
Continuous audible clicks, viewing window
Customization
Yes
Download specifications

Needle Isolation Technology (NIT®)

NIT® is a market-proven, pre-attached needle technology for cartridge-based injections that eliminates the need for patients to manually attach the needle. NIT provides complete control of cannula gauge and length to support target injection time and injection depth.  

The first NIT-enabled autoinjector received regulatory approval in 2017 for a metabolic treatment. In 2024, a second device was approved for treatment of two dermatological conditions.  

NIT-20250708

A more convenient injection experience

By combining Needle Isolation Technology (NIT®) with a cartridge-based design, SHL Medical developed the Maggie® autoinjector to meet the growing demands for large-volume subcutaneous delivery. 

Explore services

Cartridge-based solutions

Maggie® is designed for large-volume subcutaneous drug delivery using a 3.0 mL cartridge with pre-installed needle.  

Maggie 3ml cartridge-based-solutions-c

Easy 2-step operation

Human factor studies show that patients find the 2-step Maggie® autoinjector to be easy to use, especially with NIT® eliminating manual steps in needle attachment. 

Maggie-3ml-instruction-1-20250704